IR News
Dec. 14, 2017Print(PDF/128KB)Corporate
Sumitomo Dainippon Pharma announces Organizational Realignment and Personnel Change
Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada) today announced that the following organizational realignment and personnel change, effective January 1, 2018:
1. Organizational Realignment (effective January 1, 2018)
Drug Research (Division)
Genomic Science Laboratories is dissolved and its functions are transferred to Sumitomo Chemical Co., Ltd.
*Transfer of functions of Genomic Science Laboratories to Sumitomo Chemical Co., Ltd. is announced today jointly with Sumitomo Chemical Co., Ltd.
2. Personnel Change (effective January 1, 2018)
Drug Research (Division)
| Position as of January 1, 2018 | Current position | Name |
|---|---|---|
Senior Director, Platform Technology Research Unit |
Senior Director, Platform Technology Research Unit |
Hidetaka Nagata |